Figure 3From: The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategiesEvolution of disease activity scores from week 24 on after retreatment in patients with or without flare. CI, confidence interval.Back to article page